Clinical Trial

SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study

Name: SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study — clinical trial record (NCT07515820)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the safety and efficacy of SHR-3821 combined with fruquintinib in the advanced colorectal cancer after failure of standard therapy

Trial Details

NCT Number	NCT07515820
Lead Sponsor	Meng Qiu Collaborators: Jiangsu Hengrui Pharmaceutical Co., Ltd.
Conditions	Colorectal Cancer
Enrollment	12 participants
Start Date	2026-04-27
Primary Completion	2027-07-28 (estimated)
Study Completion	2028-04-28 (estimated)
Updated on ClinicalTrials.gov	2026-04-07